Cbx4控制HIF-1α参与Th9细胞分化,通过其SUMO E3结合酶活性促进喘
Wufeng Huang1, Changhui Yu2, Hong Wu2
1Department of Respiratory and Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China; People's Hospital of Huazhou City. Huazhou 525100, Guangdong Province, China.
Biochimica et biophysica acta. Molecular cell research
|June 22, 2023
概括
聚合物染色盒4 (Cbx4) 通过SUMOylation增加缺氧诱导因子-1α (HIF-1α) 活性,促进Th9细胞分化,从而增强喘. 抑制 Cbx4 的作用
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 喘病原发生涉及复杂的分子途径,包括缺氧诱导因子-1 (HIF-1).
- 在喘中,Polycomb chromobox 4 (Cbx4),一种SUMO E3结合酶的作用尚不清楚.
研究的目的:
- 为了研究Cbx4和缺氧诱导因子-1α (HIF-1α) 之间的相互作用.
- 阐明Cbx4影响喘进展的机制.
主要方法:
- 进行了体外和体外实验.
- 研究涉及评估蛋白质相互作用,化和交换活化.
- 用一只喘小鼠模型来评估治疗干预措施.
主要成果:
- 通过其SUMO E3结合酶活性,Cbx4直接与HIF-1α相互作用,增强HIF-1α结合和交换.
- 这种相互作用促进了Th9细胞的分化,加剧了喘.
- 针对Cbx4或HIF-1α SUMO E3酶活性的抑制剂降低了HIF-1α激活和Th9细胞分化,减轻了小鼠的喘.
结论:
- Cbx4通过其SUMO E3结合酶功能调节HIF-1α活性和Th9细胞分化,有助于喘进展.
- 针对Cbx4-HIF-1α相互作用,为喘提供了一个潜在的治疗策略.
更多相关视频
相关概念视频
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357


